Nuventra Pharma Sciences is now Allucent. Learn more here.

Innovative solutions to
keep your project on course

PK/PD Modeling and Simulation

Modeling and simulation have become indispensable in drug development. Using modeling and simulation, existing data can be leveraged to provide important insights on product safety and effectiveness as related to drug concentration. These insights can be used to inform clinical trial design and predict trial outcomes. They can also help drug developers select appropriate doses for first-in-human (FIH) clinical trials or in special populations, such as renal and hepatic impairment or pediatric patients.

Together, the information and insights gleaned from modeling and simulation provide not only opportunities for a more efficient drug development program, but they also provide key support for marketing application submissions. Indeed, the FDA and EMA have both included modeling and simulation among their highest priorities to support efficient drug development and facilitate regulatory decision making.

With modeling and simulation, your existing data can answer many important questions and save significant time and money. Model-based drug development consists of the use of mathematical and statistical methods to:

  • Understand how various dosing choices (e.g., dose, dose frequency, dosing duration) affect drug concentrations
  • Clarify the relationship between drug concentration and desired or undesired pharmacodynamic responses
  • Characterize the PK/PD variability of drugs and assist in understanding the clinically relevant factors contributing to variability
  • Predict the impact of formulation changes on drug performance (i.e., in vivo bioavailability) using in vitro/in vivo correlations (IVIVC)

Modeling and Simulation Services

Nuventra has an expert team of pharmacometricians who build models tailored to guide your drug development program’s decisions. As part of these services, our team will create a custom, model-based drug development plan that will facilitate the selection of the most salient model for your compound and disease area.

Contact us today to learn how Nuventra’s modeling and simulation services can help you gain insights that move your clinical development program forward.

Contact Us

Case Study: A Unique Modeling and Simulation Strategy

Explore Our Blog

Compartmental Modeling in Pharmacokinetics

Pharmacokinetic (PK) modeling is a tool used to help drug developers understand a drug’s effects on the body by analyzing…

Read More

Determining First-in-Human (FIH) Dose for Clinical Studies

First-in-Human (FIH) studies are designed and conducted based on nonclinical data submitted to and reviewed by regulatory authorities. For the…

Read More

How to Use Modeling and Simulation to Optimize a 505(b)(2) Application

A 505(b)(2) application is a hybrid of a full new drug application and an abbreviated new drug application. The terms…

Read More